{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:25:42Z","timestamp":1768782342416,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University Research Board (URB) grant from the American University of Beirut (AUB)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ijantimicag.2010.10.009","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T04:41:09Z","timestamp":1291437669000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB\/c mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Elias A.","family":"Rahal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Kazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kanbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Abdelnoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan M.","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/76.11.1154","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"76","author":"Elliott","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0010","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0015","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268800051153","article-title":"Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers","volume":"112","author":"Louie","year":"1994","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-123-9-199511010-00009","article-title":"Escherichia coli O157:H7 infection in humans","volume":"123","author":"Su","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199508103330608","article-title":"Escherichia coli O157:H7 and the hemolytic\u2013uremic syndrome","volume":"333","author":"Boyce","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1532-5415.2006.00682.x","article-title":"Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak","volume":"54","author":"Reiss","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOG.0b013e3282f2dfb8","article-title":"Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections","volume":"24","author":"Serna","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1987.tb02249.x","article-title":"Inhibition of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes by Shiga-like toxin I (VT1) from Escherichia coli O157:H7 and by Shiga toxin","volume":"44","author":"Igarashi","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-1033.1988.tb13756.x","article-title":"Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes, RNA N-glycosidase activity of the toxins","volume":"171","author":"Endo","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0882-4010(88)90054-X","article-title":"Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes","volume":"4","author":"Ogasawara","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0065","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)01267-7","article-title":"Escherichia coli O157:H7","volume":"352","author":"Mead","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/mr.51.2.206-220.1987","article-title":"Shiga and Shiga-like toxins","volume":"51","author":"O\u2019Brien","year":"1987","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0075","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1046\/j.1523-1755.2000.00126.x","article-title":"Many cell types are Shiga toxin targets","volume":"57","author":"Meyers","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0080","first-page":"487","article-title":"The hemolytic uremic syndromes","volume":"11","author":"Caprioli","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/315239","article-title":"Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice","volume":"181","author":"Zhang","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3810\/pgm.1998.02.358","article-title":"Enterohemorrhagic Escherichia coli. A dangerous food-borne pathogen","volume":"103","author":"Qadri","year":"1998","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0095","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0100","first-page":"1209","article-title":"Using antibiotics in suspected haemolytic\u2013uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infection","volume":"330","author":"Dundas","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3201\/eid0605.000503","article-title":"Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response","volume":"6","author":"Kimmitt","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1179\/000349803235002146","article-title":"Inhibition of the transcription of the Escherichia coli O157:H7 genes coding for Shiga-like toxins and intimin, and its potential use in the treatment of human infection with the bacterium","volume":"97","author":"Matar","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0115","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0890-8508(05)80014-3","article-title":"A nested PCR followed by magnetic separation of amplified fragments for detection of Escherichia coli Shiga-like toxin genes","volume":"5","author":"Olsvik","year":"1991","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0125","series-title":"Basic exercises in immunochemistry: a laboratory manual","article-title":"Determination of toxicity","author":"Nowotny","year":"1979"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0130","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/iai.60.8.3464-3467.1992","article-title":"Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation","volume":"60","author":"Karch","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2006.03036.x","article-title":"Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?","volume":"24","author":"Panos","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2010.10.009_bib0140","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ijfoodmicro.2009.12.019","article-title":"Contemporary strategies in combating microbial contamination in food chain","volume":"141","author":"Rajkovic","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10482-009-9391-y","article-title":"Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains","volume":"97","author":"Yoshimura","year":"2010","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s430-001-8021-9","article-title":"A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice","volume":"189","author":"Shu","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijfoodmicro.2006.04.041","article-title":"Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB\/c mice","volume":"111","author":"Gagnon","year":"2006","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0160","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.72.4.2240-2247.2004","article-title":"Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7","volume":"72","author":"Asahara","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4315\/0362-028X-72.2.325","article-title":"Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against enterohemorrhagic Escherichia coli O157:H7","volume":"72","author":"Lee","year":"2009","journal-title":"J Food Prot"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijfoodmicro.2010.01.035","article-title":"Antimicrobial action of the American cranberry constituents; phenolics, anthocyanins, and organic acids, against Escherichia coli O157:H7","volume":"139","author":"Lacombe","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.10.009_bib0175","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/596509","article-title":"Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection","volume":"199","author":"Zhang","year":"2009","journal-title":"J Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910004565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910004565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:30:38Z","timestamp":1760376638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910004565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0924857910004565"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}